Baxter Shines Light On Conservative Kidney Treatment, Time To Transform

General Manager, Baxter Malaysia, George Kazzi

Multinational healthcare company, Baxter will support 2021’s World Kidney Day under the theme of “Living Well with Kidney Disease”.

According to a study by Thamil Arasu Saminathan and Lai Seong Hooi, Prevalence of Chronic Kidney Disease and its Associated Factors in Malaysia, kidney disease affects approximately 10 percent of the global population, and 15.48 percent of the general population in Malaysia.

Baxter’s vision is to transform comprehensive conservative (renal) care and give patients flexibility when it [renal care] comes to treatment and care of chronic conditions.

General Manager of Baxter Malaysia, George Kazzi said that the Covid-19 outbreak has brought into sharp focus the need to help patients gain access to home dialysis, where patients can socially distance during this health crisis.

“We believe kidney care is a journey that should begin with symptom management (chronic kidney disease management) before dialysis is required. If dialysis is required along the journey, eligible patients should have access to home therapy to support their quality of life, and to help them maintain social distance during the Covid-19 outbreak.

In addition to being at higher risk for contracting viruses, a recent study on Covid-19 infection among US dialysis patients shows that dialysis patients who contracted Covid-19 indicated they experienced a nearly 25 mortality rate,” he added.

Baxter has been supporting the kidney disease community through the partnership with the nephrologist community, especially the Malaysian Society of Nephrology, MYBuahPinggang and the National Kidney Foundation (NKF).

In Malaysia, Baxter advocates to increase awareness and knowledge about the impact of kidney disease, the treatment options available and help patients in making informed decisions via various platforms such as public education website, Your Dialysis Journey.

LEAVE A REPLY

Please enter your comment!
Please enter your name here